Attached files
| file | filename |
|---|---|
| EX-31.1 - EX-31.1 - F-star Therapeutics, Inc. | d77314dex311.htm |
| EX-32.1 - EX-32.1 - F-star Therapeutics, Inc. | d77314dex321.htm |
| EX-31.2 - EX-31.2 - F-star Therapeutics, Inc. | d77314dex312.htm |
| EX-23.1 - EX-23.1 - F-star Therapeutics, Inc. | d77314dex231.htm |
| EX-10.11.3 - EX-10.11.3 - F-star Therapeutics, Inc. | d77314dex10113.htm |
| EX-10.11.2 - EX-10.11.2 - F-star Therapeutics, Inc. | d77314dex10112.htm |
| EX-10.9 - EX-10.9 - F-star Therapeutics, Inc. | d77314dex109.htm |
| 10-K - 10-K - F-star Therapeutics, Inc. | d77314d10k.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of F-star Therapeutics, Inc. (the “Company”) on Form 10-K for the period ending December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
| Date: March 30, 2021 |
By: |
/s/ Darlene Deptula-Hicks | ||
| Darlene Deptula-Hicks | ||||
| Chief Financial Officer and Treasurer |